• #1047522
  • 334
  • Glaxo Smith Kline #58160097620

Bexsero® Meningitis Vaccine For Individuals 10 Through 25 Years of Age Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection Prefilled Syringe 10 Syringes

BEXSERO, PFS 0.5ML (10/BX) RX

Features
  • BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syringe
  • More …
  Log In to Order
or
 View Alternatives

Product Specifications

McKesson #1047522
Manufacturer #58160097620
BrandBexsero®
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
Alternate Manufacturer Number3605193
ApplicationMeningitis Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
Generic Drug Code35944
Generic Drug NameMeningococcal Group B Vaccine
NDC Number58160097620
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Storage RequirementsRequires Refrigeration
Strength50 mcg - 50 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201610
UserFor Individuals 10 Through 25 Years of Age
Volume10 Syringes
Features
  • BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
  • BEXSERO is approved for use in individuals 10 through 25 years of age
  • BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syringe
More Information

Professionals Also Viewed

Glaxo Smith Kline 58160095509

  • #1064517
  • 316
  • Glaxo Smith Kline #58160095509
Menveo® Meningitis Vaccine Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, Preservative Free 10 mcg - 5 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL

  • MENVEO is a vaccine indicated for active immunization to prevent invas …
  • MENVEO is supplied in two vials that must be combined prior to adminis …
Pfizer 00005010005

  • #944569
  • 105
  • Pfizer #00005010005
Trumenba® Meningitis Vaccine For Individuals 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 5 Syringes

  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
Pfizer 00005010010

  • #944570
  • 48
  • Pfizer #00005010010
Trumenba® Meningitis Vaccine For Individuals 10 Through 25 Years of Age Meningococcal Group B Vaccine 120 mcg / 0.5 mL Injection Prefilled Syringe 10 Syringes

  • Trumenba is indicated for active immunization to prevent invasive dise …
  • Trumenba is a suspension for intramuscular injection in 0.5 mL single- …
Sanofi Pasteur 589-05

  • #581508
  • 734
  • Sanofi Pasteur #589-05
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL

  • Menactra is indicated for active immunization of individuals 2 through …
  • Menactra vaccine is administered as a 0.5 mL dose by intramuscular inj …
  • In children 9 through 23 months of age, Menactra is given as a 2-dose …